UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER IMAGE: BASED ON VIRTUAL AND IN VITRO ANTIVIRAL SCREENING THAT BEGAN IN THE EARLIER MONTHS OF THE COVID-19 PANDEMIC, THE RESEARCHERS LED AT UTHSC BY COLLEEN JONSSON, PHD, IDENTIFIED ZUCLOPENTHIXOL, NEBIVOLOL AND AMODIAQUINE AS A PROMISING THERAPEUTICS FOR TEH VIRUS IN ITS EARLY STAGES. Memphis, Tenn. (November 18, 2020)–Researchers at...